A 2-Day Training Course Delivered By
Lieven Annemans

Prof. Dr. Lieven Annemans

  • Prof. Dr. Lieven Annemans has participated in more than 400 health economic evaluations in over 20 countries across a wide spectrum of therapeutic areas. He has also been involved as an expert in a large number of Health Technology Assessments (HTAs) and is actively involved in HTA on a European level.
  • A unique profile: academic professor, past-president ISPOR, consultant and former pharma executive.
  • Highly respected for his vast international and cross-therapeutic experience, Lieven is a much sought-after advisor and educator to health policy makers and the innovative healthcare industry.
  • Author of Health economics for non-economists (Pelckmans Pro, 2018).

Learn

  1. The full meaning of QALYs and ICERs, and how to calculate them.
  2. Commonly used health economic modelling techniques.
  3. Key principles of cost analysis and budget impact analysis.
  4. The 10 guidelines for conducting and reporting health economic evaluations.
  5. How to assess peer reviewed health economic articles.
  6. How health economic evaluations are integrated in clinical trial programmes.
  7. The use of health economic evaluations in pricing & reimbursement decision making.
  8. The importance of health economic evaluations along the innovation life cycle.

Additional Benefits

  • A training by Prof. Dr. Lieven Annemans combines very productive learning with great fun!
  • Exchange experiences and discuss issues with your peers from other companies, functions, therapy areas and countries.

 

Why You Should Attend

The Content: This health economics course not only provides you with an explanation of concepts and methods, it also discusses the integration of health economic evaluations in clinical development and brand marketing plans (with practical examples), as well as the perspective of the decision maker - including examples of successful applications of health economic evaluations.

The Expert: Prof. Dr. Lieven Annemans not only has a wide international experience in health economic evaluations (over 200 completed projects with over 30 different pharmaceutical or medical device companies) but also built a very strong reputation within the international pharmaco-economic community as a high-impact trainer. Throughout his career, Lieven has worked in pharmaceutical companies, in health care policy environments, in consultancy and in academic positions.

The Health Economics for Non-Health-Economists course is the only available public training course delivered by Prof. Lieven Annemans on the topic of health economics.

What is the difference with the Basics of Health Economics online self-study programme ?

  • The 2-day face-to-face course has more breadth and depth in both theory (lectures) and practice (group work). For instance, the 2-hour module on the “Guidelines for Health Economic Evaluations” is highly valued because of the interactive group work session on a health economic publication.
  • In a face-to-face classroom training, you learn a lot from your industry peers because of the exchange of experiences and ideas and the discussions about issues you face in your function. The Q&A sessions are very rich and you will have many opportunities for conversations with your peers outside the formal programme.
  • Participating in the 2-day course gives the opportunity to meet Prof. Dr. Lieven Annemans and discuss your own projects/issues with him during the breaks.

Agenda of the Health Economics for Non-Health-Economists course

Important: all hours are noted in CET/Brussels Time, so carefully convert into your local time zone!

Short breaks will be offered throughout the day.
 

Day 1

 

10:00

Welcome & General Introduction (~30 min)

 

Health Economic Evaluations: Why and How (~1 h 15 min)

 

  • Why health economic evaluations receive increasing attention
  • Key definitions & terminology: talking the same language
  • Key principles of health economic evaluations
    • QALY: the maths – examples
    • Balancing costs vs. health effect
    • The Incremental Cost-Effectiveness Ratio (ICER) and its thresholds

 

Health Economic Modelling – Commonly Used Models (~1 h 15 min)

 
  • Simple decision trees (+ real examples)
  • Markov models (+ real examples)
13:00Lunch Break

14:00

Cost Analysis and Budget Impact Analysis. Key Principles (~1 h 45 min)

 
  • The perspective of the study (e.g. building in absenteeism in the value message?)
  • How to deal with current benefits versus benefits in the far future?
  • Budget impact implications: state-of-the-art
  • Exercise on budget impact

 

Prospective Research for Health Economic Evaluations (~1 h 45 min: 1 h 15 min on day 1, 30 min on day 2)

 
  • Aligning the collection of health economic data and clinical data
  • Conflicts between the clinical and the health economic perspective
  • Practical steps for prospective health economic studies
  • Issues with integrating clinical data in health economic evaluations
  • Break-Out Session: “To HE or not to HE?”

17:00

Close

 

Day 2

 

09:30

Recap of Day 1 through Exercises on QALYs & ICERs (~45 min)

 

Prospective Research for Health Economic Evaluations (~ 30 min, continued from day 1)

 

Guidelines for Health Economic Evaluations (~2 h 15 min)

 

  • What distinguishes a good from a bad health economic evaluation?
  • What can one do to increase the credibility of health economic messages in the value message?
  • A 10-item checklist for a good health economic paper
  • Break-Out Session: how to distinguish a good health economic paper from a poor quality paper
13:00Lunch Break

14:00

Use of Health Economic Evaluations in Price & Reimbursement Decision Making (~1 h 15 min)

 
  • The large differences in payer expectations
  • Communication challenge: from very simple messages to high tech requirements
  • Pitfalls of health economic evaluations: why some messages fail
  • The secrets behind the QALY

 

Health Economic Evaluations in a Pharmaceutical Drug’s Life Cycle (~30 min)

 
  • Role of early economic models
  • Organisation and process within HQ and affiliates
  • Post-launch and the use of real world data

 

Break-Out Session: Developing Together a Health Economic Strategy (~1 h)

 

Final Discussion (~15 min)

17:00

Close

>> Click here if you wish to receive the PDF brochure of this course

Learning Methodology

Prof. Lieven Annemans is very experienced in leading interactive sessions and will actively engage participants in discussions. In addition, two exercises will be used to help bring theory into practice.

One of the most valuable aspects of attending any CELforPharma course is not only being able to have your specific questions answered by a leading expert, but also having the opportunity to share experiences and have in-depth discussions with your international peers.

infoThe typical audience size of our courses ranges from 6 to 20 (max) participants.

Who Should Attend?

As the course title suggests, this course is designed for non-health-economists.

As pharma companies are facing ever-increasing hurdles to optimise market access for their brands, all managers in product development and marketing should attend this course so that they can contribute to a successful integration of health economic evaluations into clinical and brand plans.

While most of the examples and exercises discussed in this course are about pharmaceuticals, this course is equally relevant to, and has always been highly valued by (see testimonials), executives from the medical devices industry.

 

Past Participants

Below is a non-exhaustive list of past participants who have benefited from attending this course.

 

Job Title

Company

Country

Medical Director BeneluxALKNetherlands
Director, Global Public Policy & AffairsAstraZenecaUnited Kingdom
Sr Medical Director, Regional Medical Affairs Head Immunology, EMEABaxaltaSwitzerland
Head of Health Economics Hospital Care DACHBaxterGermany
Market Access Manager, Asia PacificBayer Healthcare PharmaceuticalsSingapore
Market Access ManagerBiogenIreland
Head Market Access & External AffairsBoehringer IngelheimNetherlands
Product Manager Immuno-Oncology SwitzerlandBristol-Myers SquibbSwitzerland
Manager, Government RelationsCelgeneBelgium
Health Outcomes & Pharmacoeconomics ManagerChiesiNetherlands
Medical AdvisorCSL BehringBelgium
Medical Director, Clinical R&D GastroFerringDenmark
Generics Portfolio & Marketing - Mature & Emerging MarketsFresenius KabiGermany
Market Access Manager NL accountsGenzymeNetherlands
Product ManagerGileadBelgium
Director Strategic Pricing & AllocationsGlaxoSmithKlineBelgium
Senior Director Commercial AssessmentGruenenthalGermany
Group Therapeutic Area DirectorJanssenHungary
Sr. Principal Product Stewardship, Compliance & EU PackagingJohnson & JohnsonBelgium
RA & Compliance ManagerLEO PharmaSwitzerland
PRA ManagerLillyNetherlands
EUCAN Customer Engagement / Experience LeadMerck Sharp & DohmeSwitzerland
Market Access Head Franchise ManagementNovartisGermany
Sr Global Product ManagerNovo NordiskSwitzerland
International Health Policy LeaderRocheSwitzerland
Medical Manager CardiovascularSanofiBelgium
Head of Market Access & Corporate AffairesTakedaSwitzerland
Director, Specialty Life Cycle Initiatives Global Specialty MedicinesTevaBelgium
Director, New Product PlanningUCBBelgium

 

Testimonials

Dates & Locations

All CELforPharma courses are held live online (hosted in Zoom) or in top-class four or five star hotels situated in easily accessible locations, either close to an international airport or near public transportation links in city centre locations.
 

  • 9-10 December 2021, Brussels (Hotel to be confirmed)

  • 22-23 March 2022, Brussels (Hotel to be confirmed)

  • 21-22 June 2022, Brussels (Hotel to be confirmed)

  • 27-28 September 2022, Brussels (Hotel to be confirmed)

  • 15-16 December 2022, Brussels (Hotel to be confirmed)

 

Hotel Booking Assistance

Having built a strong relationship with each hotel, CELforPharma has secured preferential room rates for our delegates who book their accommodation three weeks or more prior to the course. Upon your registration, we will help you make your hotel booking. For any assistance in this matter please do not hesitate to contact Kealeigh Steel, Course Administrator (kealeigh.steel@celforpharma.com, tel +32 (0)2 709 01 45).

Included in the Registration Fee​

  • Participation in a small-class (max 20 participants), expert led face-to-face course with interactive group exercises and plenary discussions. You will have the opportunity to meet the expert(s) and discuss your own projects/issues during the breaks.
  • Course material, which will be provided to you in both digital format (by email) and in hard copy (so you can make notes during the course).
  • Coffee, tea & refreshments during the course.
  • Informal networking lunch.
  • Certificate of attendance signed by the expert and CELforPharma.

 

Group Discounts

Team discounts can be offered to 3 or more delegates from the same company.
Contact Annelies Swaan, Director Business Operations, (aswaan@celforpharma.com) for more details.

 

How to Register

  1. Click the "Register Here" button on this page.
  2. Choose a course date, then fill out your personal details and company / invoicing details.
  3. Choose to pay via bank transfer or by credit card.
  4. Click "Confirm Registration". You will be sent an automatic email confirming your registration followed by a personal email containing an invoice and further payment instructions.

For assistance in registering, raising a PO or invoicing, please do not hesitate to contact Kealeigh Steel.
(email: kealeigh.steel@celforpharma.com or call: +32 2 709 01 45)

 

Transfer & Cancellation Policy

Flexible Transfer

  • If a registrant cannot attend the scheduled course, he/she can avoid any cancellation charge by sending a suitable replacement participant.
  • Alternatively, the registrant can transfer once at no extra cost, until 3 weeks prior to the event, to another course held within one year of the original course date.

Participant Cancellation

  • Up to 6 weeks prior to the course: cancellation fee of € 400 per participant.
  • Up to 5 weeks prior to the course: 25% of the invoiced registration fee.
  • Up to 4 weeks prior to the course: 50% of the invoiced registration fee.
  • Up to 3 weeks prior to the course: 75% of the invoiced registration fee.
  • Fewer than 3 weeks or if no notification received: registrant liable to pay invoiced registration fee.
  • If a registrant postpones his/her participation to a future course, and cancels again, no refund can be claimed for registration fees.

Related Courses